DTC adverts probe: An opportunity for the US industry
This article was originally published in Clinica
Executive Summary
Members of the US Congress have, for some time, been debating whether and how to crack down on direct-to-consumer (DTC) advertising of prescription pharmaceuticals.
You may also be interested in...
US: The sun shines in on industry-doctor relationships
The US healthcare reform proposals signed into law on 23 March include requirements on medical device companies to reveal payments or gifts they make to doctors. Peter Rixon takes a closer look at what the reforms’ “sunshine” provisions actually mean
Global regulators/industry to gather in US and Germany to talk device regulation
Compliance, approvals, inspections and many other burning issues will be on the agenda of a US conference that takes place in the coming weeks.
Global regulators and industry execs to gather in US and Germany to talk device regulation
Compliance, approvals, inspections and many other burning issues will be on the agenda of a US conference that takes place in early May.